BioSpace News Archive

Mercury Medical recently received MDR CE Mark Certification for their CPR manual resuscitation line.

Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has received approvals from the U.S. and EU regulatory authorities to manufacture JYNNEOS®/IMVANEX® smallpox and monkeypox vaccine at the Company’s fill and finish facility in Denmark.

Nephros, Inc. today announced that it will file its second-quarter financial results on Wednesday, August 10, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, will report second quarter 2022 financial results on August 9, 2022 and will host a conference call at 8:30 a.m. ET that day.

Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the second quarter ended June 30, 2022.

Alimera Sciences, Inc. today announced financial results for the second quarter of 2022.

QurAlis Corporation , a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced that Kasper Roet , Ph.D., founder and chief executive officer, will present at the H.C. Wainwright Private Company.

Ensysce Biosciences, Inc. announced today the data from the Part B, Bioequivalence (BE) arm of the PF614-102 study examining the Company’s novel Trypsin-Activated Abuse-Protected (TAAP) Opioid, PF614.

Agenus (NASDAQ: AGEN) an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced it will release its second quarter 2022 financial results before the market opens on Tuesday, August 9, 2022.

The PSMA-PET[1] imaging agent Illuccix® from Telix Pharmaceuticals Limited (Telix) has been used in combination with the uEXPLORER®, a first-of-its kind total-body PET scanner from United Imaging for the first time.